David Malka - Publications

Third-line treatment of biliary tract cancers in a real-life setting.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

Gastric cancer with peritoneal metastases: hype or hope for HIPEC?

Journal: The Lancet. Oncology

Published: May 03, 2026

Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 22, 2026

Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patients.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Prognostic and Predictive Values of Transcriptomic Signatures in Metastatic Pancreatic Cancer: A Biomarker Analysis of Three French Multicenter Prospective Randomized Controlled Phase 2 Trials (Prodige35, Prodige37 and AFUGEM).

Journal: Cancer letters

Published: January 23, 2026

Randomized, multicenter Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or gemcitabine in patients with resected ampullary adenocarcinoma.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 31, 2025

Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 23, 2025

Antiangiogenic therapy for advanced biliary tract cancers: promising or illusory?

Journal: Journal of gastrointestinal oncology

Published: November 16, 2025

Targeting the liver: Insights from a tertiary center on post-operative hepatic arterial oxaliplatin for metastatic colorectal cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 04, 2025

Reply to letter comments on: Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine).

Journal: ESMO open

Published: May 27, 2025

Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170].

Journal: The Lancet regional health. Europe

Published: May 19, 2025

Young-onset biliary tract cancers: Characteristics, treatment patterns, and patient outcomes.

Journal: JHEP reports : innovation in hepatology

Published: May 13, 2025